These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18093141)

  • 21. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
    Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
    Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration.
    Merrigan MM; Sambol SP; Johnson S; Gerding DN
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S46-50. PubMed ID: 19303570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant lipoprotein-based vaccine candidates against C. difficile infections.
    Huang JH; Wu CW; Lien SP; Leng CH; Hsiao KN; Liu SJ; Chen HW; Siu LK; Chong P
    J Biomed Sci; 2015 Aug; 22(1):65. PubMed ID: 26245825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits.
    Caglar K; Aybay C; Ataoglu H
    APMIS; 2005 Apr; 113(4):256-63. PubMed ID: 15865606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
    Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
    Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
    Munro P; Flatau G; Lemichez E
    Vaccine; 2007 Dec; 25(52):8702-6. PubMed ID: 18035455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
    Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
    Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.
    Permpoonpattana P; Hong HA; Phetcharaburanin J; Huang JM; Cook J; Fairweather NF; Cutting SM
    Infect Immun; 2011 Jun; 79(6):2295-302. PubMed ID: 21482682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenicity of Mycobacterium paratuberculosis superoxide dismutase in mice.
    Mullerad J; Hovav AH; Fishman Y; Barletta RG; Bercovier H
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):81-8. PubMed ID: 12208610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.
    Evans JT; Cluff CW; Johnson DA; Lacy MJ; Persing DH; Baldridge JR
    Expert Rev Vaccines; 2003 Apr; 2(2):219-29. PubMed ID: 12899573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.
    Ghose C; Eugenis I; Sun X; Edwards AN; McBride SM; Pride DT; Kelly CP; Ho DD
    Emerg Microbes Infect; 2016 Feb; 5(2):e8. PubMed ID: 26839147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization strategies for Clostridium difficile infections.
    Rebeaud F; Bachmann MF
    Expert Rev Vaccines; 2012 Apr; 11(4):469-79. PubMed ID: 22551032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile: development of a novel candidate vaccine.
    Foglia G; Shah S; Luxemburger C; Pietrobon PJ
    Vaccine; 2012 Jun; 30(29):4307-9. PubMed ID: 22682287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colonization for the prevention of Clostridium difficile disease in hamsters.
    Sambol SP; Merrigan MM; Tang JK; Johnson S; Gerding DN
    J Infect Dis; 2002 Dec; 186(12):1781-9. PubMed ID: 12447764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.
    Torres JF; Lyerly DM; Hill JE; Monath TP
    Infect Immun; 1995 Dec; 63(12):4619-27. PubMed ID: 7591115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.